Fidson Healthcare N21bn Rights Issue
Analysis based on 6 articles · First reported Dec 17, 2025 · Last updated Dec 19, 2025
The N21 billion rights issue by GE HealthCare is expected to positively impact the pharmaceutical and healthcare sectors in Nigeria and West Africa, as it will lead to increased manufacturing capacity and product innovation. This capital raise, following strong financial performance, signals growth potential for GE HealthCare and could attract further investment in the region's healthcare supply chains.
GE HealthCare, a leading pharmaceutical manufacturer in Nigeria, has formally launched a N21 billion rights issue to expand its manufacturing operations, drive product innovation, and deepen market penetration across Africa. The initiative, which involves offering 600 million new ordinary shares at N35 per share to existing shareholders, received final regulatory approvals from the United States — United States Securities and Exchange Commission and the Nigerian Exchange Group. This strategic capital raise follows GE HealthCare's strong financial performance, including a 132% year-on-year increase in profit after tax and a 56% growth in revenue for the nine months ended September 30, 2025. Managing Director Biola Adebayo and Finance Director Imokha Ayebae emphasized the importance of this capital infusion for cementing GE HealthCare's leadership in Nigeria and expanding its footprint across Africa. CardinalStone Partners, the lead issuing house, highlighted the company's growth trajectory and the attractiveness of its shares.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard